Manuals & Guidelines
Lebanese Guidelines For Erythropoiesis-Stimulating Agents (ESAs) Approval in Non-Dialysis Chronic Kidney Disease (ND-CKD) Patients aT the MOPH
Author: MOPH
Source: MOPH
Source: MOPH
1-ESA initiation
- Address iron deficiency before ESA therapy initiation (iron deficiency defined as ferritin<100 ng/ml and/or transferrin saturation (TSAT)<20%).
- ESA requisition forms that lack ferritin and TSAT values will be returned.
- If Hb ≥ 10 g/dl, ESA will be approved only if patient symptomatic with a ferritin >100 ng/ml and TSAT >20%, otherwise rejected.
- If Hb 9-10 g/dl, ESA will be approved if ferritin>100 ng/ml and TSAT >20%, otherwise rejected.
- If Hb<9 g/dl and ferritin<100 ng/ml and/or TSAT<20%, ESA will be approved for one month and renewed only if ferritin>100 ng/ml and TSAT>20%.
- If Hb< 9g/dl and ferritin>100 ng/ml and TSAT>20%, ESA will be approved...
Download the new version of the Ministry of Public Health application and discover new features providing reliable health information
and advanced digital services.
The new version allows you to scan medicine barcodes to verify whether the medication is officially registered with the Ministry of Public Health and distributed through approved official channels, contributing to enhanced patient safety and reducing counterfeit and illegal medicines. In addition to other healthcare services, including:
- Tracking medication records on MediTrack
- Locating the nearest healthcare facility
- Accessing information and statistics on nurseries
- Following the latest health news and updates
The Ministry encourages citizens to rely exclusively on the official application as a trusted source for accurate and reliable health information.
